heterocycle or heterocyclic ring, as used herein except where noted, represents a stable 5- to 7-membered monocyclic-, or stable 7- to 11-membered bicyclic heterocyclic ring system, any ring of which may be saturated or unsaturated, and which consists of carbon atoms and from one to three heteroatoms selected from the group consisting of N, O and S, and wherein the nitrogen and sulfur heteroatoms may optionally be oxidized, and the nitrogen heteroatom may optionally be quaternized, and including any bicyclic group in which any of the above-defined heterocyclic rings is fused to a benzene ring
Khorram, O., Laughlin, G
This is only prescribed if the patient meets certain indications: - Patient is at least 18 years of age - Patient is receiving calcium and Vitamin D supplementation if dietary intake is inadequate - Patient must not have hypocalcemia - Patient has not had a myocardial infarction or stroke within the preceding year - The injection will not be used in combination with bisphosphonates, denosumab, or parathyroid hormone analogs/related peptides - Patient must be at a high risk for fracture, or have multiple risk factors for fracture - Patient has a documented diagnosis of osteoporosis ## **Documentation requirements for J3111** As with any HCPCS code, it's important to have sufficient documentation that satisfies your insurer's coding guidelines, requirements, related policy articles, and local coverage determinations
Stronger products may be more likely to cause redness, tingling, itching, dryness, or irritation, especially if your skin barrier is already sensitive
The Ontario Drug Benefit (ODB) database was used to identify patients who were prescribed vitamin B12 injections, and the Ontario Health Insurance Plan database was used to identify all physician claims for intramuscular injections as well as laboratory tests assessing vitamin B12 levels